Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.6M Sell
37,596
-424
-1% -$145K 3.32% 12
2026
Q1
$13.4M Sell
38,020
-644
-2% -$230K 3.28% 12
2025
Q4
$12.7M Buy
38,664
+214
+0.6% +$67.9K 2.99% 15
2025
Q3
$10.9M Buy
38,450
+338
+0.9% +$98K 2.49% 23
2025
Q2
$10.6M Buy
38,112
+449
+1% +$127K 2.57% 20
2025
Q1
$11.7M Buy
37,663
+211
+0.6% +$62.3K 2.86% 17
2024
Q4
$9.76M Buy
37,452
+76
+0.2% +$22.5K 2.41% 23
2024
Q3
$12M Buy
37,376
+359
+1% +$117K 2.93% 14
2024
Q2
$11.6M Buy
37,017
+179
+0.5% +$52.6K 2.94% 14
2024
Q1
$10.5M Buy
36,838
+245
+0.7% +$71.7K 2.65% 20
2023
Q4
$10.5M Buy
36,593
+83
+0.2% +$22.6K 2.86% 16
2023
Q3
$9.81M Sell
36,510
-585
-2% -$146K 2.87% 14
2023
Q2
$8.24M Buy
37,095
+194
+0.5% +$45K 2.29% 29
2023
Q1
$8.92M Buy
36,901
+97
+0.3% +$23.8K 2.53% 22
2022
Q4
$9.67M Sell
36,804
-267
-0.7% -$71.6K 2.8% 14
2022
Q3
$8.36M Sell
37,071
-300
-0.8% -$72.7K 2.73% 18
2022
Q2
$9.09M Buy
37,371
+606
+2% +$149K 2.75% 18
2022
Q1
$8.89M Buy
36,765
+575
+2% +$132K 2.35% 26
2021
Q4
$8.14M Buy
36,190
+1,016
+3% +$214K 2.04% 31
2021
Q3
$7.48M Buy
35,174
+1,490
+4% +$343K 2.18% 30
2021
Q2
$8.21M Buy
+33,684
New +$8.29M 2.47% 24

Other funds holding AMGN

HFR Wealth Management's AMGN Position: Q2 2026 in Review

HFR Wealth Management reduced its Amgen (AMGN) stake by 1.1% in Q2 2026, selling an estimated $145K and leaving 37,596 shares worth $13.6M. The position accounts for 3.32% of the portfolio, ranked #12.

HFR Wealth Management first reported a position in AMGN in Q2 2021 and has held it in 21 quarters since. 3,133 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • HFR Wealth Management held 37,596 shares of Amgen worth $13.6M as of Q2 2026.
  • HFR Wealth Management sold 424 Amgen shares in Q2 2026, an estimated $145K.
  • Amgen made up 3.32% of HFR Wealth Management's portfolio in Q2 2026, its #12 holding.
  • HFR Wealth Management first reported a position in Amgen in Q2 2021 and has held it in 21 quarters since.
  • 3,133 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on HFR Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.